Complex coronary cases
OCT Guided Complex Intervention of LM and Long Calcified Aneurysmal LAD – January 2020

Case and Plan:

76-year-old female presented with new onset CCS Class III angina with positive SPECT MPI for mild lateral ischemia. A Cardiac Cath on January 6, 2020 revealed 3 V + LM CAD: 70% distal LM, 80% proximal LAD/D1 bifurcation, 80% long calcified aneurysmal mid LAD, 80% LCx-OM1, SYNTAX Score of 35 and LVEF of 60%. In view of high SYNTAX Score, patient was referred for Heart Team discussion with recommendation for CABG, which was declined and patient opted for multi-vessel PCI. Patient underwent RCA PCI using Xience Sierra DES and discharged home. Now planned for OCT guided complex intervention of LM and long calcified aneurysmal proximal to mid LAD lesions.

Q&A
Q
So, what is the correct duration of DAPT?
A.

The field of DAPT duration post DES is in flux at this time. Based on the recent RCTs, Aspirin should be given for 3 months along with Ticagrelor (or clopidogrel in elderly pts and in pts with high bleeding risk) for 1-3years and then switch to aspirin mono-therapy.


Q
For ACS?
A.

Above strategy (Prasugrel can replace Ticagrelor) for atleast 1year for ACS pts and can be reduced to 6M in stable or high bleeding risk pts.


Q
And for stable lesion?
A.

Above strategy for 6M in stable CAD pts.


Q
When can one expect guideline changes for abbreviated duration of DAPT?
A.

New DAPT guidelines are expected to be released in 3Q of 2020.


Q
Is Aspirin completely on the way out?
A.

Yes aspirin will be out after a short duration of 1-3 months.


Q
Where will we have the application of QFR?
A.

QFR is derived from a new software for coronary physiological assessment, which in my opinion will be useful in cases involving the diffuse disease where it will help to get the optimal PCI results.


Q
What is your preference between Ticagrelor, Prasugrel and Clopidogrel?
A.

Based on the ISAR React -5 trial results, we are now favoring Prasugrel over Ticagrelor in ACS pts less then 75yrs of age or Pt’s at low bleeding risk. In older pts and in pts with high bleeding risk, Clopidogrel remains the main agent. In stable complex CAD pts, Ticagrelor (based on TWILIGHT trial) is preferred over Prasugrel as we donot have data for Prasugrel in stable CAD pts.


Q
I What has been the impact of ISCHEMIA in your institution?
A.

Overall impact of ISCHEMIA trial is negligible at our institution as we have done a good job of educating our cardiology community appropriately.


Q
Any impact from EXCEL?
A.

So far EXCEL trial controversy also has not affected our referral patters for LMCA revascularization; high Syntax score cases getting CTS consultation before proceeding for PCI (which is being done in about half of the cases due to Pt’s and family preference).


Q
Do you always perform co-registration during OCT?
A.

Co-registration of angiographic view during OCT acquisition is recent tool being used routinely for last 2 years. It really helps us to localize the stent related issues, if any and then rectify them accordingly.


comments

Join the Discussion

One thought on “OCT Guided Complex Intervention of LM and Long Calcified Aneurysmal LAD – January 2020”

  1. Dr Ajay Aggarwal says:

    Can stent be placed in distal om if surgeon not willing to put graft there


Leave a Reply

Your email address will not be published. Required fields are marked *

suggestion
Suggestions
Radial PCI of Long Complex Calcified LAD post TAVR – September 2020
Views 58

Case and Plan: 78 year-old-male presented on August 7, 2020 with progressive exertional dyspnea, NYHA class III. Workup revealed severe AS (AVA 0.7cm2), normal LV function and STS mortality of 1.1%. After heart team discussion, patient underwent successful TAVR using 26mm SAPIEN-3 Ultra with excellent results, AV area of 2.0cm2 and no PVL. A coronary […]


Stent Ablation with RA of Underexpanded Multilayer DES – August 2020
Tags: | |
Views 310

63 year-old male with known CAD, CABG x2 (1999) and multiple PCI’s to SVG to RCA and LCx branches presented with CCS Class IV angina and non-STEMI (TnI 1.2U). A Cardiac Cath on June 22, 2020 revealed patent LIMA to LAD, non obstructive LCx branches with patent prior stents and 90% multilayer in-stent restenosis of […]


Imaging Guided PCI of DES CTO RCA – July 2020
Views 645

57 year-old male with extensive CAD and PCI’s presented with crescendo angina on 8/20/2019 and Cath revealed 3 V CAD with DES CTO of RCA and normal LV function. CABG was recommended, but declined and patient did well on MMT. Recently started having angina and underwent Rota DES PCI of LAD/D1 bifurcation. Now planned for […]


IVUS Guided Orbital Atherectomy and DES of Tortuous Calcified LAD – June 2020
Views 690

Case and Plan: 72-year-old male presented with rest angina and Non-STEMI, peak TnI 7.6. A Cardiac Cath on February 6, 2020 revealed 3 V CAD: 95% ulcerated proximal RCA, severely calcified 80-90% proximal and mid LAD, 80% proximal LCx, 70% proximal Ramus Intermedius with LVEF 45% and SYNTAX Score of 32. Patient underwent successful culprit […]